N4BP2L1

N4BP2L1 is a transcriptionally regulated adaptor protein implicated in adipocyte glucose handling, tumor cell invasion, and modulation of membrane-type matrix metalloproteinase activity (PMID:34197691, PMID:27184799, PMID:38345408). Its expression is controlled at the promoter level by USF1, which binds an E-box in the N4BP2L1 promoter to drive transcription, and N4BP2L1 knockdown impairs adipocyte differentiation (PMID:31440585). In adipocytes it is additionally a FoxO1 target subject to insulin-mediated regulation, and it physically associates with the dynactin complex to modulate GLUT4 translocation and glucose uptake, linking it to microtubule motor-dependent vesicle trafficking (PMID:34197691). In cancer contexts N4BP2L1 acts as a pro-invasive and pro-proliferative effector situated downstream of inhibitory microRNAs: it is repressed by miR-448 in oral squamous cell carcinoma, where its knockdown reduces invasion (PMID:27184799), and is a direct miR-150-5p target in bladder cancer, where it sustains proliferation and migration through effectors including CDK4, Cyclin D1, and the EMT markers N-cadherin and E-cadherin (PMID:38910572). N4BP2L1 also binds the C-terminal domain of MT5-MMP and potentiates its η-secretase cleavage of amyloid precursor protein (PMID:38345408). Beyond these interaction- and phenotype-level findings, no catalytic activity or structural mechanism for N4BP2L1 has been characterized in the available corpus.

1. 2016 Medium

   Established the first functional role for N4BP2L1, placing it downstream of a microRNA regulatory axis as a driver of tumor cell invasion.

   Evidence siRNA knockdown with invasion assay, cDNA microarray, and miR-448 overexpression in oral squamous cell carcinoma

   PMID:27184799

   Open questions at the time

   • No molecular mechanism connecting N4BP2L1 to the invasion machinery
   • Direct miR-448 targeting of the N4BP2L1 transcript not demonstrated (inverse correlation only)
2. 2019 Medium

   Identified an upstream transcriptional control mechanism for N4BP2L1 and a role in adipogenesis, answering how the gene is regulated.

   Evidence Luciferase reporter, EMSA, ChIP showing USF1 binding the N4BP2L1 promoter E-box, plus siRNA knockdown with adipocyte differentiation marker readout

   PMID:31440585

   Open questions at the time

   • Mechanism by which N4BP2L1 promotes differentiation not defined
   • No downstream effector or interaction partner identified in this study
3. 2021 Medium

   Connected N4BP2L1 to insulin/FoxO1 signaling and to dynactin-dependent vesicle trafficking, providing the first physical interaction partner and a mechanistic link to glucose metabolism.

   Evidence Reporter assay for FoxO1 regulation, immunoprecipitation of N4BP2L1–dynactin, GLUT4 translocation and glucose uptake assays with adenoviral gain- and loss-of-function in 3T3-L1 adipocytes

   PMID:34197691

   Open questions at the time

   • Which dynactin subunit N4BP2L1 contacts is not resolved
   • Whether N4BP2L1 directly bridges GLUT4 vesicles to the dynein/dynactin motor is not shown
   • Single lab, no reciprocal/structural validation of the interaction
4. 2024 Medium

   Defined a direct physical interaction with MT5-MMP and a functional consequence (enhanced η-secretase APP cleavage), extending N4BP2L1 function to proteolytic processing.

   Evidence Yeast two-hybrid screen with MT5-MMP C-terminal domain bait against a human brain cDNA library, plus sAPPη production assay

   PMID:38345408

   Open questions at the time

   • Interaction shown by Y2H and activity readout but not confirmed in a structural or endogenous setting
   • How N4BP2L1 binding potentiates MT5-MMP activity mechanistically is unknown
   • Physiological relevance to APP processing in vivo not established
5. 2024 Medium

   Confirmed N4BP2L1 as a direct miRNA target controlling proliferation and migration, generalizing its pro-tumor role across cancer types.

   Evidence Luciferase reporter for direct miR-150-5p targeting, siRNA knockdown and overexpression, western blot for CDK4/Cyclin D1/Bcl-2/PCNA/Ki-67/cadherins, proliferation and migration assays in bladder cancer cells

   PMID:38910572

   Open questions at the time

   • How N4BP2L1 mechanistically regulates the cell-cycle and EMT effectors is not defined
   • Whether the cancer and adipocyte functions share a common molecular mechanism is unknown

• The biochemical activity of N4BP2L1 — whether it is a scaffold, adaptor, or carries enzymatic function — remains undefined, as does the structural basis for its diverse interactions with dynactin and MT5-MMP.
• No defined molecular activity
• No structural model
• No unifying mechanism linking adipocyte, cancer, and APP-processing roles